Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
9
×
Tags
life sciences
9
×
national blog main
startups
9
×
biotech
boston blog main
national top stories
boston top stories
clinical trials
deals
fda
new york blog main
san francisco blog main
boston
investing
new york top stories
san diego blog main
san diego top stories
san francisco top stories
sanofi
cancer
chronic rhinosinusitis
decibel therapeutics
flagship pioneering
glaxosmithkline
ipo
laurence reid
lyra therapeutics
medical device
pulmonary arterial hypertension
raleigh-durham blog main
renaissance capital
san diego
sr one
steven holtzman
vc
480 biomedical
abbvie
acceleron pharma
achaogen
acid sphingomyelinase deficiency
What
therapeutics
9
×
medicines
drug
new
biotech
disease
ago
company
debut
developing
drugs
field
million
momentum
raised
year
years
adding
address
adds
aiming
aims
allosteric
announced
approach
athena
backs
bacteria
balance
based
bets
bio
biopharma
black
build
building
business
called
cancer
ceo
Language
unset
Current search:
therapeutics
×
startups
×
photo
×
" life sciences "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed